Sponsors: []Modifications:     58-1-501.3.(1)  For purposes of this section:(a)  "Drug to treat a sexually transmitted disease" means a drug:(i)  as defined in Section 

58-17b-102

; and(ii)  that is:(A)  an antibiotic; and(B)  prescribed in accordance with guidelines from the Centers for Disease Control andPrevention for patient delivered expedited partner therapy in the management of sexuallytransmitted disease.(b)  "Partner" means a person:(i)  with whom a practitioner does not have a bonafide practitioner-patient relationship;and(ii)  who is identified as, or claims to be a sexual partner of a patient.(c)  "Patient" means a person who:(i)  has a sexually transmitted disease; and(ii)  has a bonafide practitioner-patient relationship with a practitioner.(d)  "Sexually transmitted disease" means:(i)  gonorrhea; or(ii)  chlamydia.(2)  This section does not require a practitioner to prescribe a drug to treat a sexuallytransmitted disease for patient delivered expedited partner therapy.  A practitioner's decision touse expedited partner therapy as allowed by this section is voluntary.(3)  Notwithstanding Sections 

58-1-501

, 

58-17b-501

, and 

58-17b-502

, it is not unlawfulconduct or unprofessional conduct, and it does not violate the provisions of this chapter if:(a)  a practitioner, in accordance with this Subsection (3):(i)  issues a prescription for a drug to treat a sexually transmitted disease to a partner by:(A)  writing "partner of (patient name)" on the prescription order; and(B)  giving the partner's prescription to the patient for subsequent use by the partner; or(ii)  notwithstanding Section 

58-17b-610

, dispenses a drug sample to treat a sexuallytransmitted disease to the patient for the subsequent use of the partner; or(b)  a pharmacist, in accordance with this Subsection (3):(i)  dispenses a prescription drug for the treatment of a sexually transmitted disease to:(A)  a person who:(I)  claims to be a partner; and(II)  presents a prescription for the drug to the pharmacist which is written for theunnamed partner of a named patient;(B)  the patient for the subsequent use by the unnamed partner; or(C)  an agent of the patient or partner.(4) (a)  For purposes of Subsection (3), and notwithstanding Section 

58-17b-602

:(i)  the partner does not have to be identified on the prescription order by informationthat would disclose the identity of the partner; and(ii)  when dispensing a drug to treat a sexually transmitted disease directly to thepartner, the patient's identifying information may, but does not need to, be included on thepartner's drug label.(b)  Information provided by a pharmacist to a patient or the patient's agent forsubsequent use by a partner satisfies the requirements of patient counseling for both the patientand the partner under Section 

58-17b-613

.Except as provided in Section 

58-1-501.3

, thea pharmacistinternthe prescriptionFull text:



Utah State Legislature












Legislators

By Session (1896-Current)
Alphabetical (Historical)
Find by Address/Map
More


Bills

Bills/Bill Requests
Passed Bills
2017 Bills

Keyword Search
Reading Calendars
Tracking Service
More


Committees

All Committees
Appropriations
Commissions

Independent Legislative Ethics Commission
Interim
Standing
Subcommittees
Task Forces
Bills In Committees


Utah Code / Constitution


Title/Chapter/Section
Keyword Search 

Utah Constitution
Laws of Utah 1851-ongoing
Utah Territorial Laws 
More


Senate

Main Page 
About The Senate 
Leadership 
Roster 
Seating Chart 
District Maps 
Extraordinary Sessions 
Reading Calendars 
Past Floor Debates 
Senate Journals 


House

Main Page
About the House 
Leadership 
Roster 
Seating Chart 
District Maps 
Reading Calendars 
Past Floor Debates 
Journals 
Conflict of Interest Forms 


Legislative Guide 

Legislative Guide
Civic Programs
GRAMA (Records Requests)


Publications

Search Publications
Appropriations
Audits
Bagels & Briefings
Briefing Papers
Digest of Legislation
Legislative Drafting Manual

Journals

Interim Highlights

Legislative Rules
GRAMA (Records Requests)
Public Email
State Organization Charts
YouTube Channel
Requests for Proposals and Legal Notices
More


Legislative Histories

Legislative History Resources
How to Research
Bill Drafting/Research Files (1990-Ongoing)

Working Bills (1896-1989)
Interim Committee Histories (1990-Ongoing) 
Journals
Past House Floor Debates
Past Senate Floor Debates
More


Staff Offices

All Legislative Offices
Auditor General
Fiscal Analyst
Printing
Research and General Counsel
Staff Awards
Job Opportunities
More


Links of Interest

Utah Administrative Rules
Courts
Utah State Capitol
State of Utah
Federal Legislation
More






 

Download Zipped Introduced WordPerfect HB0017.ZIP
[Status][Bill Documents][Fiscal Note][Bills Directory]


H.B. 17





            
1

    
 EXPEDITED PARTNER THERAPY TREATMENT



            
2

    
2009 GENERAL SESSION

            
3

    
STATE OF UTAH

            
4

    


 Chief Sponsor:  Jennifer M. Seelig



            
5

    



Senate Sponsor: 






  Stephen H. Urquhart





            
6

    

            
7

    
 LONG TITLE
            
8

    
 Committee Note:
            
9

    
    The Health and Human Services Interim Committee recommended this bill.
            
10

    
 General Description:
            
11

    
    This bill amends the Pharmacy Practice Act in the Division of Occupational and
            
12

    
Professional Licensing Act.
            
13

    
 Highlighted Provisions:
            
14

    
    This bill:
            
15

    
    .    defines terms;
            
16

    
    .    excludes from the definition of unprofessional conduct and unlawful conduct under
            
17

    
the Division of Occupational and Professional Licensing, issuing a prescription for
            
18

    
an antibiotic to an unnamed partner of a person who has any one of certain
            
19

    
designated sexually transmitted diseases;
            
20

    
    .    does not mandate the use of expedited partner therapy;
            
21

    
    .    provides an option for physicians to use expedited partner therapy;
            
22

    
    .    makes conforming changes to the Pharmacy Practices Act; and
            
23

    
    .    makes technical changes.
            
24

    
 Monies Appropriated in this Bill:
            
25

    
    None
            
26

    
 Other Special Clauses:
            
27

    
    None

            
28


    
 Utah Code Sections Affected:
            
29

    
AMENDS:
            
30

    
     58-17b-602, as last amended by Laws of Utah 2007, Chapter 279
            
31

    
ENACTS:
            
32

    
     58-1-501.3, Utah Code Annotated 1953
            
33

    

            
34

    
Be it enacted by the Legislature of the state of Utah:
            
35

    
    Section 1.  
Section  
58-1-501.3

 is enacted to read:
            
36

    
     58-1-501.3.  Health professional prescribing exceptions for expedited partner
            
37

    
 therapy for sexually transmitted diseases.
            
38

    
    (1)  For purposes of this section:
            
39

    
    (a)  "Drug to treat a sexually transmitted disease" means a drug:
            
40

    
    (i)  as defined in Section 

58-17b-102

; and
            
41

    
    (ii)  that is:
            
42

    
    (A)  an antibiotic; and
            
43

    
    (B)  prescribed in accordance with guidelines from the Centers for Disease Control and
            
44

    
Prevention for patient delivered expedited partner therapy in the management of sexually
            
45

    
transmitted disease.
            
46

    
    (b)  "Partner" means a person:
            
47

    
    (i)  with whom a practitioner does not have a bonafide practitioner-patient relationship;
            
48

    
and
            
49

    
    (ii)  who is identified as, or claims to be a sexual partner of a patient.
            
50

    
    (c)  "Patient" means a person who:
            
51

    
    (i)  has a sexually transmitted disease; and
            
52

    
    (ii)  has a bonafide practitioner-patient relationship with a practitioner.
            
53

    
    (d)  "Sexually transmitted disease" means:
            
54

    
    (i)  gonorrhea; or
            
55

    
    (ii)  chlamydia.
            
56

    
    (2)  This section does not require a practitioner to prescribe a drug to treat a sexually
            
57

    
transmitted disease for patient delivered expedited partner therapy.  A practitioner's decision to
            
58

    
use expedited partner therapy as allowed by this section is voluntary.

            
59


    
    (3)  Notwithstanding Sections 

58-1-501

, 

58-17b-501

, and 

58-17b-502

, it is not unlawful
            
60

    
conduct or unprofessional conduct, and it does not violate the provisions of this chapter if:
            
61

    
    (a)  a practitioner, in accordance with this Subsection (3):
            
62

    
    (i)  issues a prescription for a drug to treat a sexually transmitted disease to a partner by:
            
63

    
    (A)  writing "partner of (patient name)" on the prescription order; and
            
64

    
    (B)  giving the partner's prescription to the patient for subsequent use by the partner; or
            
65

    
    (ii)  notwithstanding Section 

58-17b-610

, dispenses a drug sample to treat a sexually
            
66

    
transmitted disease to the patient for the subsequent use of the partner; or
            
67

    
    (b)  a pharmacist, in accordance with this Subsection (3):
            
68

    
    (i)  dispenses a prescription drug for the treatment of a sexually transmitted disease to:
            
69

    
    (A)  a person who:
            
70

    
    (I)  claims to be a partner; and
            
71

    
    (II)  presents a prescription for the drug to the pharmacist which is written for the
            
72

    
unnamed partner of a named patient;
            
73

    
    (B)  the patient for the subsequent use by the unnamed partner; or
            
74

    
    (C)  an agent of the patient or partner.
            
75

    
    (4) (a)  For purposes of Subsection (3), and notwithstanding Section 

58-17b-602

:
            
76

    
    (i)  the partner does not have to be identified on the prescription order by information
            
77

    
that would disclose the identity of the partner; and
            
78

    
    (ii)  when dispensing a drug to treat a sexually transmitted disease directly to the
            
79

    
partner, the patient's identifying information may, but does not need to, be included on the
            
80

    
partner's drug label.
            
81

    
    (b)  Information provided by a pharmacist to a patient or the patient's agent for
            
82

    
subsequent use by a partner satisfies the requirements of patient counseling for both the patient
            
83

    
and the partner under Section 

58-17b-613

.
            
84

    
    Section 2.  
Section  
58-17b-602

 is amended to read:
            
85

    
     58-17b-602.  Prescription orders -- Information required -- Alteration -- Labels --
            
86

    
 Signatures -- Dispensing in pharmacies.
            
87

    
    (1)  [The] Except as provided in Section 

58-1-501.3

, the minimum information that
            
88

    
shall be included in a prescription order, and that may be defined by rule, is:
            
89

    
    (a)  the prescriber's name, address, and telephone number, and, if the order is for a

            
90


    
controlled substance, the patient's age and the prescriber's DEA number;
            
91

    
    (b)  the patient's name and address or, in the case of an animal, the name of the owner
            
92

    
and species of the animal;
            
93

    
    (c)  the date of issuance;
            
94

    
    (d)  the name of the medication or device prescribed and dispensing instructions, if
            
95

    
necessary;
            
96

    
    (e)  the directions, if appropriate, for the use of the prescription by the patient or animal
            
97

    
and any refill, special labeling, or other instructions;
            
98

    
    (f)  the prescriber's signature if the prescription order is written;
            
99

    
    (g)  if the order is an electronically transmitted prescription order, the prescribing
            
100

    
practitioner's electronic signature; and
            
101

    
    (h)  if the order is a hard copy prescription order generated from electronic media, the
            
102

    
prescribing practitioner's electronic or manual signature.
            
103

    
    (2)  The requirement of Subsection (1)(a) does not apply to prescription orders
            
104

    
dispensed for inpatients by hospital pharmacies if the prescriber is a current member of the
            
105

    
hospital staff and the prescription order is on file in the patient's medical record.
            
106

    
    (3)  Unless it is for a Schedule II controlled substance, a prescription order may be
            
107

    
dispensed by [pharmacists] a pharmacist or pharmacy [interns] intern upon an oral prescription
            
108

    
of a practitioner only if the oral prescription is promptly reduced to writing.
            
109

    
    (4) (a)  Except as provided under Subsection (4)(b), a pharmacist or pharmacy intern
            
110

    
may not dispense or compound any prescription of a practitioner if [it] the prescription shows
            
111

    
evidence of alteration, erasure, or addition by any person other than the person writing the
            
112

    
prescription.
            
113

    
    (b)  A pharmacist or pharmacy intern dispensing or compounding a prescription may
            
114

    
alter or make additions to the prescription after receiving permission of the prescriber and may
            
115

    
make entries or additions on the prescription required by law or necessitated in the
            
116

    
compounding and dispensing procedures.
            
117

    
    (5)  Each drug dispensed shall have a label securely affixed to the container indicating
            
118

    
the following minimum information:
            
119

    
    (a)  the name, address, and telephone number of the pharmacy;
            
120

    
    (b)  the serial number of the prescription as assigned by the dispensing pharmacy;

            
121


    
    (c)  the filling date of the prescription or its last dispensing date;
            
122

    
    (d)  the name of the patient, or in the case of an animal, the name of the owner and
            
123

    
species of the animal;
            
124

    
    (e)  the name of the prescriber;
            
125

    
    (f)  the directions for use and cautionary statements, if any, which are contained in the
            
126

    
prescription order or are needed;
            
127

    
    (g)  except as provided in Subsection (6), the trade, generic, or chemical name, amount
            
128

    
dispensed and the strength of dosage form, but if multiple ingredient products with established
            
129

    
proprietary or nonproprietary names are prescribed, those products' names may be used; and
            
130

    
    (h)  the beyond use date.
            
131

    
    (6)  If the prescriber specifically indicates the name of the prescription product should
            
132

    
not appear on the label, then any of the trade, generic, chemical, established proprietary, and
            
133

    
established nonproprietary names and the strength of dosage form may not be included.
            
134

    
    (7)  Except when it is delivered to the ultimate user via the United States Postal Service,
            
135

    
licensed common carrier, or supportive personnel, a prescription drug may be dispensed to the
            
136

    
ultimate user or his agent only at a licensed pharmacy.




 Legislative Review Note
    as of  11-19-08  3:36 PM

 Office of Legislative Research and General Counsel
[Bill Documents][Bills Directory]









Who represents me?





Remember my Legislators





State Senate
		350 North State, Suite 320
		PO Box 145115
		Salt Lake City, Utah 84114

		Telephone: (801) 538-1035
		Fax: (801) 326-1475



House of Representatives
		350 North State, Suite 350
		PO Box 145030
		Salt Lake City, Utah 84114

		Telephone: (801) 538-1029
		Fax: (801) 326-1544










Home
Mobile Site
Site Map
Calendar
Code / Constitution
House
Senate

Terms of Use/Privacy Policy

ADA
Utah.gov







